Isomers Clear Skin Acne Treatment Gel

Product NDC: 64990-601
11-digit product format: 649900601
Labeler code: 64990
Product ID: 64990-601_9532a7db-9aab-44ae-8e35-12d0e74b8f9b
Type: HUMAN OTC DRUG
Nonproprietary name: Salicylic Acid
Dosage form: GEL
Route: TOPICAL
Labeler: Isomers Laboratories Inc
Application: part333D
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2009-12-28
Marketing end: 0000-00-00
Substance: SALICYLIC ACID
Active strength: 0 mL/mL
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 8 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	64990-601		I	Inactivated by FDA	2026-10-05
excluded product	product	64990-601		I	Inactivated by FDA	2026-10-05
excluded product	product	64990-601		I	Inactivated by FDA	2026-10-05
excluded product	product	64990-601		I	Inactivated by FDA	2026-10-05
excluded package	package	64990-601	64990-601-01	I	Inactivated by FDA	2026-10-05
excluded package	package	64990-601	64990-601-03	I	Inactivated by FDA	2026-10-05
excluded package	package	64990-601	64990-601-04	I	Inactivated by FDA	2026-10-05
excluded package	package	64990-601	64990-601-02	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 3 · 176 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64990-601-04	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64990-601-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64990-601-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64990-601-03	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64990-601-04	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64990-601-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64990-601-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64990-601-03	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64990-601-04	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64990-601-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64990-601-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64990-601-03	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64990-601-04	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64990-601-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64990-601-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64990-601-03	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64990-601-04	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64990-601-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64990-601-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64990-601-03	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64990-601-04	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64990-601-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64990-601-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64990-601-03	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64990-601-04	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64990-601-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64990-601-02	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64990-601-03	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Indexing SPL, Related label table
NDC	Indexing SPL	Related label
64990-601-01	956f9ecf-c108-621f-e053-dbdaa90a74ad	DRUG FACTS
64990-601-02	956f9ecf-cef1-621f-e053-dbdaa90a74ad	DRUG FACTS
64990-601-03	956f9ecf-cbe5-621f-e053-dbdaa90a74ad	DRUG FACTS
64990-601-04	956f9ecf-c24f-621f-e053-dbdaa90a74ad	DRUG FACTS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
64990-601-03	Isomers Clear Skin Acne Treatment Gel	240 mL in 1 BOTTLE	GEL	240	5
64990-601-04	Isomers Clear Skin Acne Spot Treatment	30 mL in 1 BOTTLE	GEL	30	3
64990-601-01	Isomers Clear Skin Acne Treatment Gel	60 mL in 1 BOTTLE	GEL	60	1
64990-601-02	Isomers Clear Skin Acne Treatment Gel	120 mL in 1 BOTTLE	GEL	120	1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	5
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	5
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	5
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	INACTIVE INGREDIENT	S38J6RZN16	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	5
OPUNTIA FICUS-INDICA	INACTIVE INGREDIENT	23Z87HTQ6P	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	5
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	5
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	5
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	5
WATER	INACTIVE INGREDIENT	059QF0KO0R	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	5
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	ISOMERS CLEAR SKIN ACNE SPOT TREATMENT (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	3
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	ISOMERS CLEAR SKIN ACNE SPOT TREATMENT (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	3
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	ISOMERS CLEAR SKIN ACNE SPOT TREATMENT (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	3
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	INACTIVE INGREDIENT	S38J6RZN16	ISOMERS CLEAR SKIN ACNE SPOT TREATMENT (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	3
OPUNTIA FICUS-INDICA	INACTIVE INGREDIENT	23Z87HTQ6P	ISOMERS CLEAR SKIN ACNE SPOT TREATMENT (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	3
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	ISOMERS CLEAR SKIN ACNE SPOT TREATMENT (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	3
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	ISOMERS CLEAR SKIN ACNE SPOT TREATMENT (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	3
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	ISOMERS CLEAR SKIN ACNE SPOT TREATMENT (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	ISOMERS CLEAR SKIN ACNE SPOT TREATMENT (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	3
Salicylic Acid	ACTIVE INGREDIENT	O414PZ4LPZ	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
Salicylic Acid	ACTIVE INGREDIENT	O414PZ4LPZ	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
Salicylic Acid	ACTIVE MOIETY	O414PZ4LPZ	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
Glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	INACTIVE INGREDIENT	S38J6RZN16	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	INACTIVE INGREDIENT	S38J6RZN16	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
OPUNTIA FICUS-INDICA	INACTIVE INGREDIENT	23Z87HTQ6P	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
OPUNTIA FICUS-INDICA	INACTIVE INGREDIENT	23Z87HTQ6P	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
Phenoxyethanol	INACTIVE INGREDIENT	HIE492ZZ3T	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
Propylene Glycol	INACTIVE INGREDIENT	6DC9Q167V3	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1
Water	INACTIVE INGREDIENT	059QF0KO0R	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
64990-601	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	5	Legacy NDC, 1 package rows	20100218_7ade773b-ba2f-4f93-9808-d0a06c61faf2.zip
64990-601	ISOMERS CLEAR SKIN ACNE SPOT TREATMENT (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	3	Legacy NDC, 1 package rows	20100308_bec3eaac-4b48-4fad-9ef7-19a175703673.zip
64990-601	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1	Legacy NDC, 1 package rows	20100122_db02b4b0-e439-11de-8a39-0800200c9a66.zip
64990-601	ISOMERS CLEAR SKIN ACNE TREATMENT GEL (SALICYLIC ACID) GEL [ISOMERS LABORATORIES INC]	1	Legacy NDC, 1 package rows	20100122_7e955990-e4c9-11de-8a39-0800200c9a66.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
O414PZ4LPZ	SALICYLIC ACID	69-72-7	SALICYLIC ACID

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
346298	salicylic acid 2 % Topical Gel	PSN	7ade773b-ba2f-4f93-9808-d0a06c61faf2	5
346298	salicylic acid 0.02 MG/MG Topical Gel	SCD	7ade773b-ba2f-4f93-9808-d0a06c61faf2	5
346298	salicylic acid 2 % Topical Gel	SY	7ade773b-ba2f-4f93-9808-d0a06c61faf2	5
346298	salicylic acid 2 % Topical Gel	PSN	bec3eaac-4b48-4fad-9ef7-19a175703673	3
346298	salicylic acid 0.02 MG/MG Topical Gel	SCD	bec3eaac-4b48-4fad-9ef7-19a175703673	3
346298	salicylic acid 2 % Topical Gel	SY	bec3eaac-4b48-4fad-9ef7-19a175703673	3
346298	salicylic acid 2 % Topical Gel	PSN	7e955990-e4c9-11de-8a39-0800200c9a66	1
346298	salicylic acid 2 % Topical Gel	PSN	db02b4b0-e439-11de-8a39-0800200c9a66	1
346298	salicylic acid 0.02 MG/MG Topical Gel	SCD	7e955990-e4c9-11de-8a39-0800200c9a66	1
346298	salicylic acid 0.02 MG/MG Topical Gel	SCD	db02b4b0-e439-11de-8a39-0800200c9a66	1
346298	salicylic acid 2 % Topical Gel	SY	7e955990-e4c9-11de-8a39-0800200c9a66	1
346298	salicylic acid 2 % Topical Gel	SY	db02b4b0-e439-11de-8a39-0800200c9a66	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
64990-601-01	64990060101	60 mL in 1 BOTTLE	60 ml	Historical
64990-601-02	64990060102	120 mL in 1 BOTTLE	120 ml	Historical
64990-601-03	64990060103	240 mL in 1 BOTTLE	240 ml	Historical
64990-601-04	64990060104	30 mL in 1 BOTTLE	30 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
DRUG FACTS	Isomers Laboratories Inc	2010-03-01	HUMAN OTC DRUG LABEL	3
DRUG FACTS	Isomers Laboratories Inc	2010-02-17	HUMAN OTC DRUG LABEL	5
DRUG FACTS	Isomers Laboratories Inc	2010-01-22	HUMAN OTC DRUG LABEL	1
DRUG FACTS	Isomers Laboratories Inc	2010-01-21	HUMAN OTC DRUG LABEL	1